Sight Sciences Inc (SGHT) support and resistance · rev $43.1M
Sight Sciences Inc (SGHT) is a medical devices company listed on NASDAQ.
This page maps Sight Sciences Inc (SGHT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SGHT revenue for 2026-06-30 was $43.1M. Net income was -$17.4M. SGHT currently screens at market cap $273.1M.
SGHT currently screens at market cap $273.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SGHT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SGHT quote page for the session range and the stock page for the full model.
Not investment advice.